Speaking Out About Breast Implant-Associated Cancer
Imagine overcoming a breast cancer diagnosis and its treatment, yet in choosing reconstructive surgery with textured implants, finding out you may be at risk for a rare type of lymphoma.
Renee Ridgeley found herself in that exact situation.
Following the recent controversy with a Food and Drug Administration panel not banning these implants that are to blame for causing breast implant-associated anaplastic large-cell lymphoma, many women are speaking out about the issue.
In this week’s CURE Talks Cancer podcast, we spoke with the patient advocate about her own experience and how women can learn more about their reconstruction options.
Read more about the FDA's panel in March at curetoday.com.